Cargando…
Pasireotide in an insulin-requiring diabetic acromegalic patient without worsening of hyperglycemia
Long-acting pasireotide is an effective treatment option for acromegaly, but it is associated with hyperglycemia, which could impact its use in patients with diabetes. We present a case of a 53-year-old man with acromegaly and type 2 diabetes mellitus (glycated hemoglobin (HbA(1c)): 7.5%), who refus...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Bioscientifica Ltd
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445444/ https://www.ncbi.nlm.nih.gov/pubmed/28567297 http://dx.doi.org/10.1530/EDM-17-0003 |